Citation of this article
Corresponding Author of This Article
Article-Type of This Article
Open-Access Policy of This Article
Times Cited Counts in Google of This Article
Number of Hits and Downloads for This Article
- Total Article Views (6534)
All Articles published online
|
Sep 14, 2011 (publication date) through Nov 29, 2024
Times Cited of This Article
Journal Information of This Article
Publication Name
World Journal of Gastroenterology
ISSN
1007-9327
Publisher of This Article
Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA
| For: | Hernández-Breijo B, Monserrat J, Ramírez-Rubio S, Cuevas EP, Vara D, Díaz-Laviada I, Fernández-Moreno MD, Román ID, Gisbert JP, Guijarro LG. Preclinical evaluation of azathioprine plus buthionine sulfoximine in the treatment of human hepatocarcinoma and colon carcinoma. World J Gastroenterol 2011; 17(34): 3899-3911 [PMID: 22025878 DOI: 10.3748/wjg.v17.i34.3899] |
|---|---|
| URL: | https://www.wjgnet.com/1007-9327/full/v17/i34/3899.htm |
| Number | Citing Articles |
| 1 |
Laïla-Aïcha Hanafi, Dominique Gauchat, Jessica Godin-Ethier, David Possamaï, Jean-Baptiste Duvignaud, Denis Leclerc, Nathalie Grandvaux, Réjean Lapointe, Michael Platten. Fludarabine Downregulates Indoleamine 2,3-Dioxygenase in Tumors via a Proteasome-Mediated Degradation Mechanism. PLoS ONE 2014; 9(6): e99211 doi: 10.1371/journal.pone.0099211
|
| 2 |
Minjong Lee, Ara Jo, Seulki Lee, Jong Bin Kim, Young Chang, Joon Yeul Nam, Hyeki Cho, Young Youn Cho, Eun Ju Cho, Jeong-Hoon Lee, Su Jong Yu, Jung-Hwan Yoon, Yoon Jun Kim, Yuan-Soon Ho. 3-bromopyruvate and buthionine sulfoximine effectively kill anoikis-resistant hepatocellular carcinoma cells. PLOS ONE 2017; 12(3): e0174271 doi: 10.1371/journal.pone.0174271
|
| 3 |
Jinda Bian, Dan Zhang, Yicun Wang, Hanjiao Qin, Wei Yang, Ranji Cui, Jiyao Sheng. Mitochondrial Quality Control in Hepatocellular Carcinoma. Frontiers in Oncology 2021; 11 doi: 10.3389/fonc.2021.713721
|
| 4 |
Luis G. Guijarro, Patricia Sanmartin-Salinas, Eva Pérez-Cuevas, M. Val Toledo-Lobo, Jorge Monserrat, Sofia Zoullas, Miguel A. Sáez, Miguel Angel Álvarez-Mon, Julia Bujan, Fernando Noguerales-Fraguas, Eduardo Arilla-Ferreiro, Melchor Álvarez-Mon, Miguel A. Ortega. Actinomycin D Arrests Cell Cycle of Hepatocellular Carcinoma Cell Lines and Induces p53-Dependent Cell Death: A Study of the Molecular Mechanism Involved in the Protective Effect of IRS-4. Pharmaceuticals 2021; 14(9): 845 doi: 10.3390/ph14090845
|
| 5 |
Michael Andresini, Arianna Tota, Leonardo Degennaro, James A. Bull, Renzo Luisi. Synthesis and Transformations of NH‐Sulfoximines. Chemistry – A European Journal 2021; 27(69): 17293 doi: 10.1002/chem.202102619
|
| 6 |
Xinlong Zang, Jinxiao Song, Yanfeng Li, Yantao Han. Targeting necroptosis as an alternative strategy in tumor treatment: From drugs to nanoparticles. Journal of Controlled Release 2022; 349: 213 doi: 10.1016/j.jconrel.2022.06.060
|
| 7 |
Nicola Traverso, Roberta Ricciarelli, Mariapaola Nitti, Barbara Marengo, Anna Lisa Furfaro, Maria Adelaide Pronzato, Umberto Maria Marinari, Cinzia Domenicotti. Role of Glutathione in Cancer Progression and Chemoresistance. Oxidative Medicine and Cellular Longevity 2013; 2013: 1 doi: 10.1155/2013/972913
|
| 8 |
QIWEI LI, XIAOBIN YIN, WEI WANG, MING ZHAN, BENPENG ZHAO, ZHAOYUAN HOU, JIAN WANG. The effects of buthionine sulfoximine on the proliferation and apoptosis of biliary tract cancer cells induced by cisplatin and gemcitabine. Oncology Letters 2016; 11(1): 474 doi: 10.3892/ol.2015.3879
|
| 9 |
Luis G. Guijarro, Patricia Sanmartin-Salinas, Eva Pérez-Cuevas, M. Val Toledo-Lobo, Jorge Monserrat, Sofía Zoullas, Miguel A. Sáez, Miguel A. Álvarez-Mon, Julia Bujan, Fernando Noguerales-Fraguas, Eduardo Arilla-Ferreiro, Melchor Álvarez-Mon, Miguel A. Ortega. Possible Role of IRS-4 in the Origin of Multifocal Hepatocellular Carcinoma. Cancers 2021; 13(11): 2560 doi: 10.3390/cancers13112560
|
| 10 |
Mohinder Pal Bansal. Redox Regulation and Therapeutic Approaches in Cancer. 2023; : 311 doi: 10.1007/978-981-99-7342-2_9
|
| 11 |
Patrick Mäder, Lars Kattner. Sulfoximines as Rising Stars in Modern Drug Discovery? Current Status and Perspective on an Emerging Functional Group in Medicinal Chemistry. Journal of Medicinal Chemistry 2020; 63(23): 14243 doi: 10.1021/acs.jmedchem.0c00960
|
| 12 |
Gökce Türkkanı, Burcu Güngör, Oğuz Cetin, Çiğdem İçhedef, Yasemin Parlak, F. Gül Gümüşer, B. Elvan Sayıt Bilgin, Serap Teksöz. Synthesis, radiolabeling and in vitro evaluation of azathioprine loaded magnetic solid lipid nanoparticles. Journal of Radioanalytical and Nuclear Chemistry 2023; 332(11): 4695 doi: 10.1007/s10967-023-08975-5
|
| 13 |
Mao-Bin Meng, Huan-Huan Wang, Yao-Li Cui, Zhi-Qiang Wu, Yang-Yang Shi, Nicholas G. Zaorsky, Lei Deng, Zhi-Yong Yuan, You Lu, Ping Wang. Necroptosis in tumorigenesis, activation of anti-tumor immunity, and cancer therapy. Oncotarget 2016; 7(35): 57391 doi: 10.18632/oncotarget.10548
|
| 14 |
Adriana Cruz, Pedro Mota, Cristiano Ramos, Rita F. Pires, Cindy Mendes, José P. Silva, Sofia C. Nunes, Vasco D. B. Bonifácio, Jacinta Serpa. Polyurea Dendrimer Folate-Targeted Nanodelivery of l-Buthionine Sulfoximine as a Tool to Tackle Ovarian Cancer Chemoresistance. Antioxidants 2020; 9(2): 133 doi: 10.3390/antiox9020133
|
| 15 |
Yuxuan Xiong, Chen Xiao, Zifu Li, Xiangliang Yang. Engineering nanomedicine for glutathione depletion-augmented cancer therapy. Chemical Society Reviews 2021; 50(10): 6013 doi: 10.1039/D0CS00718H
|
| 16 |
Paolo Mattiolo, Ares Barbero-Farran, Víctor J. Yuste, Jacint Boix, Judit Ribas. 2-Phenylethynesulfonamide (PES) uncovers a necrotic process regulated by oxidative stress and p53. Biochemical Pharmacology 2014; 91(3): 301 doi: 10.1016/j.bcp.2014.08.005
|
| 17 |
Claudia Rita Corso, Alexandra Acco. Glutathione system in animal model of solid tumors: From regulation to therapeutic target. Critical Reviews in Oncology/Hematology 2018; 128: 43 doi: 10.1016/j.critrevonc.2018.05.014
|
| 18 |
Camila dos Reis Oliveira, Joedna Cavalcante Pereira, Andressa Barros Ibiapina, Italo Rossi Roseno Martins, João Marcelo de Castro e Sousa, Paulo Michel Pinheiro Ferreira, Felipe Cavalcanti Carneiro da Silva. Buthionine sulfoximine and chemoresistance in cancer treatments: a systematic review with meta-analysis of preclinical studies. Journal of Toxicology and Environmental Health, Part B 2023; 26(8): 417 doi: 10.1080/10937404.2023.2246876
|
| 19 |
Ulrich Lücking. Sulfoximine: Eine vernachlässigte Chance in der medizinischen Chemie. Angewandte Chemie 2013; 125(36): 9570 doi: 10.1002/ange.201302209
|
| 20 |
Ulrich Lücking. Sulfoximines: A Neglected Opportunity in Medicinal Chemistry. Angewandte Chemie International Edition 2013; 52(36): 9399 doi: 10.1002/anie.201302209
|
| 21 |
Jan Borlinghaus, Jana Foerster (née Reiter), Ulrike Kappler, Haike Antelmann, Ulrike Noll, Martin Gruhlke, Alan Slusarenko. Allicin, the Odor of Freshly Crushed Garlic: A Review of Recent Progress in Understanding Allicin’s Effects on Cells. Molecules 2021; 26(6): 1505 doi: 10.3390/molecules26061505
|
| 22 |
Borja Hernández-Breijo, Jorge Monserrat, Irene D. Román, Águeda González-Rodríguez, Mª Dolores Fernández-Moreno, Mª Val T. Lobo, Ángela M. Valverde, Javier P. Gisbert, Luis G. Guijarro. Azathioprine desensitizes liver cancer cells to insulin-like growth factor 1 and causes apoptosis when it is combined with bafilomycin A1. Toxicology and Applied Pharmacology 2013; 272(3): 568 doi: 10.1016/j.taap.2013.07.024
|
| 23 |
Stephan Philipp, Justyna Sosna, Dieter Adam. Cancer and necroptosis: friend or foe?. Cellular and Molecular Life Sciences 2016; 73(11-12): 2183 doi: 10.1007/s00018-016-2193-2
|
| 24 |
Sylwia Wrotek, Krzysztof Domagalski, Tomasz Jędrzejewski, Eliza Dec, Wiesław Kozak. Buthionine sulfoximine, a glutathione depletor, attenuates endotoxic fever and reduces IL-1β and IL-6 level in rats. Cytokine 2017; 90: 31 doi: 10.1016/j.cyto.2016.10.005
|
| 25 |
Isabel Rodríguez-Gómez, Javier Carmona-Cortés, Rosemary Wangensteen, Pablo Vargas-Tendero, Inmaculada Banegas, Andrés Quesada, Ángel M. García-Lora, Félix Vargas. The pro-oxidant buthionine sulfoximine (BSO) reduces tumor growth of implanted Lewis lung carcinoma in mice associated with increased protein carbonyl, tubulin abundance, and aminopeptidase activity. Tumor Biology 2014; 35(8): 7799 doi: 10.1007/s13277-014-2046-2
|
| 26 |
Qingbin Cui, Jing-Quan Wang, Yehuda G. Assaraf, Liang Ren, Pranav Gupta, Liuya Wei, Charles R. Ashby, Dong-Hua Yang, Zhe-Sheng Chen. Modulating ROS to overcome multidrug resistance in cancer. Drug Resistance Updates 2018; 41: 1 doi: 10.1016/j.drup.2018.11.001
|